PTGS2 and prostate intraepithelial neoplasia: Percentage of COX2+ cell coverage in tumors from evanescent prostate carcinoma was even significantly smaller than percent of area covered by COX2+ cells in PIN and prostate cancer samples (0.13 ± 0.06, p < 0.0001 vs all patient cohorts).